Skip to main content
. 2009 Mar 24;388(4):815–823. doi: 10.1016/j.jmb.2009.03.042

Fig. 4.

Fig. 4

Ribbon representation of the F26G19 Fab–RBD complex and the m396 Fab–RBD,22 80R scFv–RBD25 and ACE2–RBD10 complexes. The heavy chain and light chain of each neutralizing antibody fragment is depicted in blue and red, respectively, the RBD is depicted in yellow and the ACE2 molecule is depicted in purple. Residues 486–492 of the RBD, which represent the major determinant of F26G19 binding, are depicted in green.